IRadimed Corporation provided earnings guidance for the full year and first quarter of 2016. For the full year 2016, the company expects to report revenue of $39.0 million to $40.0 million and non-GAAP diluted earnings per share of $0.83 to $0.85.

For the first quarter of 2016, the company expects to report revenue of $9.0 million to $9.1 million and non-GAAP diluted earnings per share of $0.17 to $0.18, an increase of 21% to 29% over the first quarter 2015 non-GAAP diluted earnings per share of $0.14.

The company expects to report revenue of approximately $8.8 million for the fourth quarter of 2015, exceeding the company's guidance of $8.5 million to $8.6 million.